US Patent 11787800 BRD9 degraders and uses thereof

Is a

Patent

Patent attributes

Patent Applicant

Foghorn Therapeutics

Current Assignee

Foghorn Therapeutics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

11787800

Patent Inventor Names

Sabine K. Ruppel

Matthew Netherton

Zhaoxia Yang

Johannes H. Voigt

Francois Brucelle

Jason T. Lowe

Date of Patent

October 17, 2023

Patent Application Number

17382543

Date Filed

July 22, 2021

Patent Citations

‌

US Patent 7232566 Methods for treating HIV infected subjects

‌

US Patent 9271978 Heterocyclic compounds as bromodomain inhibitors

‌

US Patent 9353051 Antiviral drugs for treatment or prevention of dengue infection

‌

US Patent 9410943 Methods, compositions and screens for therapeutics for the treatment of synovial sarcoma

‌

US Patent 10105420 Methods, compositions and screens for therapeutics for the treatment of synovial sarcoma

‌

US Patent 10464925 Methods to induce targeted protein degradation through bifunctional molecules

‌

US Patent 10646575 Heterocyclic degronimers for target protein degradation

‌

US Patent 10660968 Spirocyclic degronimers for target protein degradation

...

Patent Primary Examiner

CPC Code

Patent abstract

The present invention relates to methods and compositions for the treatment of BAF-related disorders such as cancers and viral infections.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

US Patent 11787800 BRD9 degraders and uses thereof

Contents

Patent attributes

Timeline

Further Resources

References

Find more entities like US Patent 11787800 BRD9 degraders and uses thereof